Safety, tolerability and effectiveness of a novel 20 Hz rTMS protocol targeting dorsomedial prefrontal cortex in major depression: An open-label case series
Brain Stimul. 2019 Sep-Oct;12(5):1319-1321.
doi: 10.1016/j.brs.2019.06.020.
Epub 2019 Jun 20.
1 MRI-Guided rTMS Clinic and Krembil Research Institute, University Health Network, Toronto, Canada; Department of Psychiatry and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Unité de Neuromodulation Psychiatrique (UNP), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montréal, Canada. Electronic address: mironjp@icloud.com.
2 Lev-Hasharon Mental Health Center, Tzur-Moshe and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
3 Departments of Psychiatry and Biomedical Engineering, University of Melbourne, Melbourne, Victoria, Australia.
4 Department of Psychiatry and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
5 Department of Psychiatry and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, Toronto, Canada.
6 Department of Psychiatry and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Temerty Centre for Therapeutic Brain Intervention at the Centre for Addiction and Mental Health, Toronto, ON, Canada.
7 MRI-Guided rTMS Clinic and Krembil Research Institute, University Health Network, Toronto, Canada; Department of Psychiatry and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.